The global market for Anticoagulants Drug was valued at US$ 31350 million in the year 2024 and is projected to reach a revised size of US$ 39220 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Anticoagulants Drug Market

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anticoagulants Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants Drug.

The Anticoagulants Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anticoagulants Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anticoagulants Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anticoagulants Drug Market Report

Report Metric	Details
Report Name	Anticoagulants Drug Market
Accounted market size in year	US$ 31350 million
Forecasted market size in 2031	US$ 39220 million
CAGR	3.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Novel Oral Anticoagulants (NOACs) Warfarin (VKA) Others
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), Portola Pharmaceuticals (US), Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), CoaguSense (US)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticoagulants Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anticoagulants Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Anticoagulants Drug Market growing?

Ans: The Anticoagulants Drug Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Anticoagulants Drug Market size in 2031?

Ans: The Anticoagulants Drug Market size in 2031 will be US$ 39220 million.

Who are the main players in the Anticoagulants Drug Market report?

Ans: The main players in the Anticoagulants Drug Market are C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), Portola Pharmaceuticals (US), Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), CoaguSense (US)

What are the Application segmentation covered in the Anticoagulants Drug Market report?

Ans: The Applications covered in the Anticoagulants Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Anticoagulants Drug Market report?

Ans: The Types covered in the Anticoagulants Drug Market report are Novel Oral Anticoagulants (NOACs), Warfarin (VKA), Others

1 Anticoagulants Drug Market Overview

1.1 Product Definition

1.2 Anticoagulants Drug by Type

1.2.1 Global Anticoagulants Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Novel Oral Anticoagulants (NOACs)

1.2.3 Warfarin (VKA)

1.2.4 Others

1.3 Anticoagulants Drug by Application

1.3.1 Global Anticoagulants Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Anticoagulants Drug Market Size Estimates and Forecasts

1.4.1 Global Anticoagulants Drug Revenue 2020-2031

1.4.2 Global Anticoagulants Drug Sales 2020-2031

1.4.3 Global Anticoagulants Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Anticoagulants Drug Market Competition by Manufacturers

2.1 Global Anticoagulants Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Anticoagulants Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Anticoagulants Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Anticoagulants Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anticoagulants Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anticoagulants Drug, Product Type & Application

2.7 Global Key Manufacturers of Anticoagulants Drug, Date of Enter into This Industry

2.8 Global Anticoagulants Drug Market Competitive Situation and Trends

2.8.1 Global Anticoagulants Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anticoagulants Drug Players Market Share by Revenue

2.8.3 Global Anticoagulants Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anticoagulants Drug Market Scenario by Region

3.1 Global Anticoagulants Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Anticoagulants Drug Sales by Region: 2020-2031

3.2.1 Global Anticoagulants Drug Sales by Region: 2020-2025

3.2.2 Global Anticoagulants Drug Sales by Region: 2026-2031

3.3 Global Anticoagulants Drug Revenue by Region: 2020-2031

3.3.1 Global Anticoagulants Drug Revenue by Region: 2020-2025

3.3.2 Global Anticoagulants Drug Revenue by Region: 2026-2031

3.4 North America Anticoagulants Drug Market Facts & Figures by Country

3.4.1 North America Anticoagulants Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Anticoagulants Drug Sales by Country (2020-2031)

3.4.3 North America Anticoagulants Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Anticoagulants Drug Market Facts & Figures by Country

3.5.1 Europe Anticoagulants Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Anticoagulants Drug Sales by Country (2020-2031)

3.5.3 Europe Anticoagulants Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anticoagulants Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Anticoagulants Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Anticoagulants Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Anticoagulants Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Anticoagulants Drug Market Facts & Figures by Country

3.7.1 Latin America Anticoagulants Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Anticoagulants Drug Sales by Country (2020-2031)

3.7.3 Latin America Anticoagulants Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anticoagulants Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Anticoagulants Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Anticoagulants Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Anticoagulants Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Anticoagulants Drug Sales by Type (2020-2031)

4.1.1 Global Anticoagulants Drug Sales by Type (2020-2025)

4.1.2 Global Anticoagulants Drug Sales by Type (2026-2031)

4.1.3 Global Anticoagulants Drug Sales Market Share by Type (2020-2031)

4.2 Global Anticoagulants Drug Revenue by Type (2020-2031)

4.2.1 Global Anticoagulants Drug Revenue by Type (2020-2025)

4.2.2 Global Anticoagulants Drug Revenue by Type (2026-2031)

4.2.3 Global Anticoagulants Drug Revenue Market Share by Type (2020-2031)

4.3 Global Anticoagulants Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Anticoagulants Drug Sales by Application (2020-2031)

5.1.1 Global Anticoagulants Drug Sales by Application (2020-2025)

5.1.2 Global Anticoagulants Drug Sales by Application (2026-2031)

5.1.3 Global Anticoagulants Drug Sales Market Share by Application (2020-2031)

5.2 Global Anticoagulants Drug Revenue by Application (2020-2031)

5.2.1 Global Anticoagulants Drug Revenue by Application (2020-2025)

5.2.2 Global Anticoagulants Drug Revenue by Application (2026-2031)

5.2.3 Global Anticoagulants Drug Revenue Market Share by Application (2020-2031)

5.3 Global Anticoagulants Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 C. H. Boehringer Sohn (Germany)

6.1.1 C. H. Boehringer Sohn (Germany) Company Information

6.1.2 C. H. Boehringer Sohn (Germany) Description and Business Overview

6.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product Portfolio

6.1.5 C. H. Boehringer Sohn (Germany) Recent Developments/Updates

6.2 Bristol-Myers Squibb (US)

6.2.1 Bristol-Myers Squibb (US) Company Information

6.2.2 Bristol-Myers Squibb (US) Description and Business Overview

6.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Product Portfolio

6.2.5 Bristol-Myers Squibb (US) Recent Developments/Updates

6.3 Johnson & Johnson (US)

6.3.1 Johnson & Johnson (US) Company Information

6.3.2 Johnson & Johnson (US) Description and Business Overview

6.3.3 Johnson & Johnson (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Johnson & Johnson (US) Anticoagulants Drug Product Portfolio

6.3.5 Johnson & Johnson (US) Recent Developments/Updates

6.4 Pfizer (US)

6.4.1 Pfizer (US) Company Information

6.4.2 Pfizer (US) Description and Business Overview

6.4.3 Pfizer (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer (US) Anticoagulants Drug Product Portfolio

6.4.5 Pfizer (US) Recent Developments/Updates

6.5 Daiichi Sankyo (Japan)

6.5.1 Daiichi Sankyo (Japan) Company Information

6.5.2 Daiichi Sankyo (Japan) Description and Business Overview

6.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Product Portfolio

6.5.5 Daiichi Sankyo (Japan) Recent Developments/Updates

6.6 Portola Pharmaceuticals (US)

6.6.1 Portola Pharmaceuticals (US) Company Information

6.6.2 Portola Pharmaceuticals (US) Description and Business Overview

6.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Product Portfolio

6.6.5 Portola Pharmaceuticals (US) Recent Developments/Updates

6.7 Roche (Switzerland)

6.7.1 Roche (Switzerland) Company Information

6.7.2 Roche (Switzerland) Description and Business Overview

6.7.3 Roche (Switzerland) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Roche (Switzerland) Anticoagulants Drug Product Portfolio

6.7.5 Roche (Switzerland) Recent Developments/Updates

6.8 Abbott (US)

6.8.1 Abbott (US) Company Information

6.8.2 Abbott (US) Description and Business Overview

6.8.3 Abbott (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Abbott (US) Anticoagulants Drug Product Portfolio

6.8.5 Abbott (US) Recent Developments/Updates

6.9 Siemens (Germany)

6.9.1 Siemens (Germany) Company Information

6.9.2 Siemens (Germany) Description and Business Overview

6.9.3 Siemens (Germany) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Siemens (Germany) Anticoagulants Drug Product Portfolio

6.9.5 Siemens (Germany) Recent Developments/Updates

6.10 Alere (US)

6.10.1 Alere (US) Company Information

6.10.2 Alere (US) Description and Business Overview

6.10.3 Alere (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Alere (US) Anticoagulants Drug Product Portfolio

6.10.5 Alere (US) Recent Developments/Updates

6.11 CoaguSense (US)

6.11.1 CoaguSense (US) Company Information

6.11.2 CoaguSense (US) Description and Business Overview

6.11.3 CoaguSense (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2020-2025)

6.11.4 CoaguSense (US) Anticoagulants Drug Product Portfolio

6.11.5 CoaguSense (US) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anticoagulants Drug Industry Chain Analysis

7.2 Anticoagulants Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anticoagulants Drug Production Mode & Process Analysis

7.4 Anticoagulants Drug Sales and Marketing

7.4.1 Anticoagulants Drug Sales Channels

7.4.2 Anticoagulants Drug Distributors

7.5 Anticoagulants Drug Customer Analysis

8 Anticoagulants Drug Market Dynamics

8.1 Anticoagulants Drug Industry Trends

8.2 Anticoagulants Drug Market Drivers

8.3 Anticoagulants Drug Market Challenges

8.4 Anticoagulants Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

C. H. Boehringer Sohn (Germany)

Bristol-Myers Squibb (US)

Johnson& Johnson (US)

Pfizer (US)

Daiichi Sankyo (Japan)

Portola Pharmaceuticals (US)

List of Tables

Table 1. Global Anticoagulants Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Anticoagulants Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Anticoagulants Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Anticoagulants Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Anticoagulants Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Anticoagulants Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Anticoagulants Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Anticoagulants Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Anticoagulants Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anticoagulants Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anticoagulants Drug, Product Type & Application

Table 12. Global Key Manufacturers of Anticoagulants Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anticoagulants Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulants Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anticoagulants Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Anticoagulants Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Anticoagulants Drug Sales Market Share by Region (2020-2025)

Table 19. Global Anticoagulants Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Anticoagulants Drug Sales Market Share by Region (2026-2031)

Table 21. Global Anticoagulants Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Anticoagulants Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Anticoagulants Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Anticoagulants Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Anticoagulants Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Anticoagulants Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Anticoagulants Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Anticoagulants Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Anticoagulants Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Anticoagulants Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Anticoagulants Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Anticoagulants Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Anticoagulants Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Anticoagulants Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Anticoagulants Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Anticoagulants Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Anticoagulants Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Anticoagulants Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Anticoagulants Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Anticoagulants Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Anticoagulants Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Anticoagulants Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Anticoagulants Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Anticoagulants Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Anticoagulants Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Anticoagulants Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Anticoagulants Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Anticoagulants Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Anticoagulants Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Anticoagulants Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Anticoagulants Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Anticoagulants Drug Sales Market Share by Type (2020-2025)

Table 53. Global Anticoagulants Drug Sales Market Share by Type (2026-2031)

Table 54. Global Anticoagulants Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Anticoagulants Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Anticoagulants Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Anticoagulants Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Anticoagulants Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Anticoagulants Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Anticoagulants Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Anticoagulants Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Anticoagulants Drug Sales Market Share by Application (2020-2025)

Table 63. Global Anticoagulants Drug Sales Market Share by Application (2026-2031)

Table 64. Global Anticoagulants Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Anticoagulants Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Anticoagulants Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Anticoagulants Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Anticoagulants Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Anticoagulants Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. C. H. Boehringer Sohn (Germany) Company Information

Table 71. C. H. Boehringer Sohn (Germany) Description and Business Overview

Table 72. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product

Table 74. C. H. Boehringer Sohn (Germany) Recent Developments/Updates

Table 75. Bristol-Myers Squibb (US) Company Information

Table 76. Bristol-Myers Squibb (US) Description and Business Overview

Table 77. Bristol-Myers Squibb (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Bristol-Myers Squibb (US) Anticoagulants Drug Product

Table 79. Bristol-Myers Squibb (US) Recent Developments/Updates

Table 80. Johnson & Johnson (US) Company Information

Table 81. Johnson & Johnson (US) Description and Business Overview

Table 82. Johnson & Johnson (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Johnson & Johnson (US) Anticoagulants Drug Product

Table 84. Johnson & Johnson (US) Recent Developments/Updates

Table 85. Pfizer (US) Company Information

Table 86. Pfizer (US) Description and Business Overview

Table 87. Pfizer (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Pfizer (US) Anticoagulants Drug Product

Table 89. Pfizer (US) Recent Developments/Updates

Table 90. Daiichi Sankyo (Japan) Company Information

Table 91. Daiichi Sankyo (Japan) Description and Business Overview

Table 92. Daiichi Sankyo (Japan) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Daiichi Sankyo (Japan) Anticoagulants Drug Product

Table 94. Daiichi Sankyo (Japan) Recent Developments/Updates

Table 95. Portola Pharmaceuticals (US) Company Information

Table 96. Portola Pharmaceuticals (US) Description and Business Overview

Table 97. Portola Pharmaceuticals (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Portola Pharmaceuticals (US) Anticoagulants Drug Product

Table 99. Portola Pharmaceuticals (US) Recent Developments/Updates

Table 100. Roche (Switzerland) Company Information

Table 101. Roche (Switzerland) Description and Business Overview

Table 102. Roche (Switzerland) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Roche (Switzerland) Anticoagulants Drug Product

Table 104. Roche (Switzerland) Recent Developments/Updates

Table 105. Abbott (US) Company Information

Table 106. Abbott (US) Description and Business Overview

Table 107. Abbott (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Abbott (US) Anticoagulants Drug Product

Table 109. Abbott (US) Recent Developments/Updates

Table 110. Siemens (Germany) Company Information

Table 111. Siemens (Germany) Description and Business Overview

Table 112. Siemens (Germany) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. Siemens (Germany) Anticoagulants Drug Product

Table 114. Siemens (Germany) Recent Developments/Updates

Table 115. Alere (US) Company Information

Table 116. Alere (US) Description and Business Overview

Table 117. Alere (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Alere (US) Anticoagulants Drug Product

Table 119. Alere (US) Recent Developments/Updates

Table 120. CoaguSense (US) Company Information

Table 121. CoaguSense (US) Description and Business Overview

Table 122. CoaguSense (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. CoaguSense (US) Anticoagulants Drug Product

Table 124. CoaguSense (US) Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Anticoagulants Drug Distributors List

Table 128. Anticoagulants Drug Customers List

Table 129. Anticoagulants Drug Market Trends

Table 130. Anticoagulants Drug Market Drivers

Table 131. Anticoagulants Drug Market Challenges

Table 132. Anticoagulants Drug Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anticoagulants Drug

Figure 2. Global Anticoagulants Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Anticoagulants Drug Market Share by Type: 2024 & 2031

Figure 4. Novel Oral Anticoagulants (NOACs) Product Picture

Figure 5. Warfarin (VKA) Product Picture

Figure 6. Others Product Picture

Figure 7. Global Anticoagulants Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Anticoagulants Drug Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Anticoagulants Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Anticoagulants Drug Market Size (2020-2031) & (US$ Million)

Figure 14. Global Anticoagulants Drug Sales (2020-2031) & (K Pcs)

Figure 15. Global Anticoagulants Drug Average Price (USD/Pcs) & (2020-2031)

Figure 16. Anticoagulants Drug Report Years Considered

Figure 17. Anticoagulants Drug Sales Share by Manufacturers in 2024

Figure 18. Global Anticoagulants Drug Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Anticoagulants Drug Players: Market Share by Revenue in Anticoagulants Drug in 2024

Figure 20. Anticoagulants Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Anticoagulants Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Anticoagulants Drug Sales Market Share by Country (2020-2031)

Figure 23. North America Anticoagulants Drug Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Anticoagulants Drug Sales Market Share by Country (2020-2031)

Figure 27. Europe Anticoagulants Drug Revenue Market Share by Country (2020-2031)

Figure 28. Germany Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Anticoagulants Drug Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Anticoagulants Drug Revenue Market Share by Region (2020-2031)

Figure 35. China Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Anticoagulants Drug Sales Market Share by Country (2020-2031)

Figure 46. Latin America Anticoagulants Drug Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Anticoagulants Drug Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Anticoagulants Drug Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Anticoagulants Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Anticoagulants Drug by Type (2020-2031)

Figure 56. Global Revenue Market Share of Anticoagulants Drug by Type (2020-2031)

Figure 57. Global Anticoagulants Drug Price (USD/Pcs) by Type (2020-2031)

Figure 58. Global Sales Market Share of Anticoagulants Drug by Application (2020-2031)

Figure 59. Global Revenue Market Share of Anticoagulants Drug by Application (2020-2031)

Figure 60. Global Anticoagulants Drug Price (USD/Pcs) by Application (2020-2031)

Figure 61. Anticoagulants Drug Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Anticoagulants Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-8H10147

Global Anticoagulants Drug Market Research Report 2025

FEATURED COMPANIES

Anticoagulants Drug Market Size

Anticoagulants Drug Market

Report Scope

Scope of Anticoagulants Drug Market Report

Core Chapters

FAQ for this report

How fast is Anticoagulants Drug Market growing?

What is the Anticoagulants Drug Market size in 2031?

Who are the main players in the Anticoagulants Drug Market report?

What are the Application segmentation covered in the Anticoagulants Drug Market report?

What are the Type segmentation covered in the Anticoagulants Drug Market report?

FEATURED COMPANIES

RELATED REPORTS